Oxidative stress and the role of antioxidants in cardiovascular risk reduction.
Schoonover
L L
LL
Washington State University, College of Pharmacy, 601 West First Avenue, Spokane, WA 99201-3899, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D002338:Carotenoids / Q000627:therapeutic use; D003067:Coenzymes; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008077:Lipoproteins, LDL / Q000378:metabolism; D000077276:Lycopene; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology*; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D019207:beta Carotene / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D003067:Coenzymes; D005609:Free Radicals; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D019207:beta Carotene; D014451:Ubiquinone; D014810:Vitamin E; D002338:Carotenoids; C024989:coenzyme Q10; D001205:Ascorbic Acid; D000077276:Lycopene